Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 16Pancreatic Neoplasms 9Stomach Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Carcinoma, Renal Cell 6Carcinoma, Hepatocellular 6Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Melanoma 5Ovarian Neoplasms 4Neoplasm Metastasis 4Carcinoma, Merkel Cell 4Turcot syndrome 3Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Head and Neck Neoplasms 3Colonic Neoplasms 3Carcinoma, Transitional Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Microsatellite Instability 2Gastrointestinal Neoplasms 2Sarcoma 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Cancer Resectable 1Mesothelioma, Malignant 1Liver Diseases 1

Interventions

Imatinib Mesylate 71Sunitinib 31regorafenib 17nilotinib 15ripretinib 13avapritinib 7Laparoscopy 5Ipilimumab 5Dasatinib 5spartalizumab 4CTLA-4 Antigen 4Blood Specimen Collection 44-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 4pexidartinib 3pazopanib 3binimetinib 3Temozolomide 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Paclitaxel 3Oxaliplatin 3Observation 3Nivolumab 3Midazolam 3Leucovorin 3Gemcitabine 3Biopsy 3Bevacizumab 3trametinib 2tanespimycin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Stromal Tumors × avelumab × Gastrointestinal × Clear all
NCT04258956 2025-09-11

AXAGIST

Maria Sklodowska-Curie National Research Institute of Oncology

Phase 2 Completed
58 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡